Objective: to describe the clinical presentation of two canines present in anaphylactic shock secondary to rattlesnake envenomation. In both cases, there was no previous documented previous envenomation event and the initial sensitization required for anaphylactic response is believed to be secondary to Crotalus atrox toxoid vaccine.
Case Description: In the first case, a 12-year-old golden retriever present for collapse, severe hematochezia, and vomiting after first time envenomation from a suspected western diamondback rattlesnake. The patient presented in severe hypovolemic shock and required aggressive fluid therapy, antivenom, anti-emetics, and pain management. The patient made a full recovery within 24 hours. In the second case, an 8-year old English setter presented for acute collapse, vomiting, and facial swelling after suspected first time envenomation from a suspected Prairie rattlesnake. The patient presented in severe hypovolemic shock with cardiac arrhythmias and required aggressive fluid therapy, antivenom, pain control, anti-emetics, and antibiotics. The patient made a full recovery after three days of hospitalization. Both patients had been previously vaccinated with the C. atrox vaccine.
Conclusion: This case report documents suspected anaphylaxis in two canine patients after first time envenomation by a rattlesnake. Both patients were previously vaccinated by the Crotalus atrox toxoid, which is hypothesized to be the initial inciting trigger.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.toxicon.2017.12.044 | DOI Listing |
Int J Mol Sci
November 2024
College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
Snakebite envenoming is a significant health threat, particularly in tropical regions, causing substantial morbidity and mortality. Traditional treatments, including antivenom therapy, have limitations and associated risks. This research aims to discover novel phytochemical antidotes for snakebites, specifically targeting the western diamondback rattlesnake () venom metalloproteinase Atrolysin.
View Article and Find Full Text PDFToxicon
November 2024
Laboratorio de Toxinopatología, Departamento de Patología, Facultad de Medicina, José E. Uriburu 950, 5(to) piso (1114), Universidad de Buenos Aires, Buenos Aires, Argentina; Instituto Nacional de Producción de Biológicos I.N.P.B. - A.N.L.I.S. ''Dr. Carlos G. Malbrán'', Ministerio de Salud, Av. Vélez Sarsfield 563 (1282), Buenos Aires, Argentina; Área Investigación y Desarrollo - Venenos, Aracnario-Serpentario. Instituto Nacional de Producción de Biológicos, A.N.L.I.S. "Dr. Carlos G. Malbrán", Av. Velez Sarsfield 563 (1282). Buenos Aires, Argentina. Electronic address:
In this work, we describe an easy, simple, and cost-effective method to assess the proteolytic activity of snake venoms. The method is based on measuring the hydrolytic halo formed by gelatin radial hydrolysis following the incubation of venoms on a solid gelatin-agarose plate. Venoms from Bothrops (B.
View Article and Find Full Text PDFCureus
August 2024
Emergency Medicine, Saint Vincent Hospital, Erie, USA.
Toxins (Basel)
August 2024
Department of Chemistry and Pharmaceutical Sciences, Division of BioAnalytical Chemistry, Faculty of Science, Amsterdam Institute of Molecular and Life Sciences, Vrije Universiteit Amsterdam, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands.
Worldwide, it is estimated that there are 1.8 to 2.7 million cases of envenoming caused by snakebites.
View Article and Find Full Text PDFInt J Mol Sci
June 2024
Department of Anesthesiology, The University of Arizona College of Medicine, Tucson, AZ 85724, USA.
Ruthenium chloride (RuCl) is widely utilized for synthesis and catalysis of numerous compounds in academia and industry and is utilized as a key molecule in a variety of compounds with medical applications. Interestingly, RuCl has been demonstrated to modulate human plasmatic coagulation and serves as a constituent of a compounded inorganic antivenom that neutralizes the coagulopathic effects of snake venom in vitro and in vivo. Using thrombelastography, this investigation sought to determine if RuCl inhibition of the fibrinogenolytic effects of venom could be modulated by vehicle composition in human plasma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!